corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 16563

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Media Release

EFSA delivers its first series of opinions on ‘general function’ health claims
European Food Safety Authority 2009 Oct 1
http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1211902914361.htm


Full text:

EFSA has published its first series of opinions on the list of ‘general function’ health claims compiled by Member States and the European Commission. Experts on EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) evaluated the scientific evidence for more than 500 claims1 . The opinions will help inform future decisions of the European Commission and Member States concerning the authorisation of health claims2 .

The opinions provide scientific advice on 523 health claims relating to over 200 foods and food components such as vitamins and minerals, fibre, fats, carbohydrates, ‘probiotic’ bacteria, and botanical substances. For approximately one third of the claims the outcomes of the evaluations were favourable as there was sufficient scientific evidence to support the claims. These related mainly to functions of vitamins and minerals, and also included dietary fibres, and fatty acids for maintenance of cholesterol levels, and sugar-free chewing gum for maintenance of dental health. Almost half of the evaluations with unfavourable outcomes were owing to a lack of information on the substance on which the claim is based, for example ‘probiotic’ bacteria and botanical substances. Without clear identification of the substance in question, the Panel could not verify that the scientific evidence provided to EFSA related to the same substance for which the health benefits are claimed.

Commenting on these first results, Professor Albert Flynn, Chair of EFSA’s NDA Panel stated: “EFSA’s independent scientific advice will help ensure that the health claims made on foods are accurate and helpful to consumers in making healthy diet choices. The scientific opinions will inform future decisions of the Commission and Member States concerning the authorisation of health claims”.

EFSA has convened a meeting with experts from Member States and the European Commission on 6 October 2009 in Brussels to discuss the evaluation of the ‘general function’ claims. A briefing document prepared for discussion at the meeting explains EFSA’s approach to the evaluation of these claims.

Between July and December 2008 EFSA received from the European Commission a draft list with 4,185 claims to be evaluated. This list was the result of a consolidation process carried out by the Commission, after examining over 44,000 claims supplied by the Member States. The Panel is proceeding with the adoption and publication of scientific opinions on the outstanding claims on the list. EFSA is liaising with the European Commission in order to define a more precise timetable for completion of the work taking into account possible additional claims to be evaluated.

NDA opinions on article 13

For media enquiries, please contact:
Lucia de Luca, Press Officer or
Steve Pagani, Head of Press Office
Tel: +39 0521 036149
Email: Press@efsa.europa.eu

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909